Waters Corporation (WAT) PB Ratio: 1.95
Is Waters Corporation’s P/B ratio high or low?
Waters Corporation's P/B ratio of 1.95 is 94% below its 5-year average of 32.36, near the low end of its 5-year range (1.77–106.91).
76.44% below its 12-month average of 8.28.
WAT PB Ratio Chart
WAT Average PB Ratio Chart
WAT Current vs Average PB Ratio Chart
WAT PB Ratio Metrics
PB RATIO
1.95
PB RATIO AVG TTM
8.28
PB RATIO AVG 3Y
13.92
PB RATIO AVG 5Y
32.36
PB RATIO AVG 10Y
28.51
PB RATIO AVG 15Y
20.34
PB RATIO AVG 20Y
17.93
CURRENT VS TTM AVG
-76.44%
CURRENT VS 3Y AVG
-85.99%
CURRENT VS 5Y AVG
-93.97%
CURRENT VS 10Y AVG
-93.16%
CURRENT VS 15Y AVG
-90.41%
CURRENT VS 20Y AVG
-89.12%
WAT Competitors' PB Ratio
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Waters Corporation (WAT) | $23.21B | 1.95 | 8.28 | 13.92 | 32.36 |
| Mettler-Toledo International Inc. (MTD) | $22.82B | N/A | 1966.63 | 623.56 | 375.27 |
| BioNTech SE (BNTX) | $22.39B | 1.01 | 1.14 | 1.16 | 2.48 |
| Veeva Systems Inc. (VEEV) | $26.31B | 3.72 | 5.84 | 6.75 | 9.02 |
| Moderna, Inc. (MRNA) | $18.71B | 2.52 | 1.61 | 2.06 | 4.93 |
| DexCom, Inc. (DXCM) | $28.92B | 9.98 | 10.89 | 16.28 | 18.92 |
| Biogen Inc. (BIIB) | $28.94B | 1.55 | 1.34 | 1.77 | 2.39 |
| Hologic, Inc. (HOLX) | $16.97B | 3.27 | 3.17 | 3.48 | 3.78 |
| IQVIA Holdings Inc. (IQV) | $30.08B | 4.93 | 5.41 | 5.98 | 6.64 |
| Medline Inc. (MDLN) | $30.90B | 2.67 | 3.19 | 3.19 | 3.19 |
P/B vs. its own history
At 1.95, P/B is cheaper than usual, sitting higher than 0% of its 20-year history.
20-year low
1.77
median
7.72
20-year high
141.10
Book Value Analysis
P/B Ratio
1.95
Market Price / Book Value per Share
Waters Corporation PB Ratio Formula & Definition
PB Ratio = Market Cap / Total Shareholders' Equity
The price-to-book ratio compares market capitalization to book value (shareholders' equity). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Waters Corporation PB Ratio FAQ
- What is the P/B ratio for Waters Corporation (WAT)?
- The P/B ratio for WAT stock is 1.95.
- Is Waters Corporation's P/B ratio high or low?
- Waters Corporation's P/B ratio of 1.95 is 94% below its 5-year average of 32.36, near the low end of its 5-year range (1.77–106.91).
- What is the TTM average P/B ratio for Waters Corporation (WAT)?
- The TTM average P/B ratio for WAT stock is 8.28.
- What is the 3Y average P/B ratio for Waters Corporation (WAT)?
- The 3Y average P/B ratio for WAT stock is 13.92.
- What is the 5Y average P/B ratio for Waters Corporation (WAT)?
- The 5Y average P/B ratio for WAT stock is 32.36.
- What is the 10Y average P/B ratio for Waters Corporation (WAT)?
- The 10Y average P/B ratio for WAT stock is 28.51.
- What is the 15Y average P/B ratio for Waters Corporation (WAT)?
- The 15Y average P/B ratio for WAT stock is 20.34.
- What is the 20Y average P/B ratio for Waters Corporation (WAT)?
- The 20Y average P/B ratio for WAT stock is 17.93.
Waters Corporation PB Ratio History
| DATE | PB RATIO |
|---|---|
| 2026-06-10 | 1.95 |
| 2026-06-09 | 1.99 |
| 2026-06-08 | 1.95 |
| 2026-06-05 | 1.96 |
| 2026-06-04 | 2.02 |
| 2026-06-03 | 2.04 |
| 2026-06-02 | 2.00 |
| 2026-06-01 | 2.03 |
| 2026-05-29 | 2.06 |
| 2026-05-28 | 1.97 |
| 2026-05-27 | 1.84 |
| 2026-05-26 | 1.82 |
| 2026-05-22 | 1.84 |
| 2026-05-21 | 1.83 |
| 2026-05-20 | 1.83 |
| 2026-05-19 | 1.79 |
| 2026-05-18 | 1.78 |
| 2026-05-15 | 1.77 |
| 2026-05-14 | 1.79 |
| 2026-05-13 | 1.80 |
| 2026-05-12 | 1.89 |
| 2026-05-11 | 8.12 |
| 2026-05-08 | 8.29 |
| 2026-05-07 | 8.18 |
| 2026-05-06 | 8.16 |
| 2026-05-05 | 7.99 |
| 2026-05-04 | 7.04 |
| 2026-05-01 | 7.17 |
| 2026-04-30 | 7.22 |
| 2026-04-29 | 6.82 |
| 2026-04-28 | 7.02 |
| 2026-04-27 | 7.00 |
| 2026-04-24 | 7.23 |
| 2026-04-23 | 7.26 |
| 2026-04-22 | 7.80 |
| 2026-04-21 | 7.82 |
| 2026-04-20 | 7.83 |
| 2026-04-17 | 7.65 |
| 2026-04-16 | 7.44 |
| 2026-04-15 | 7.61 |
| 2026-04-14 | 7.72 |
| 2026-04-13 | 7.58 |
| 2026-04-10 | 7.47 |
| 2026-04-09 | 7.41 |
| 2026-04-08 | 7.43 |
| 2026-04-07 | 7.17 |
| 2026-04-06 | 7.10 |
| 2026-04-02 | 7.10 |
| 2026-04-01 | 7.00 |
| 2026-03-31 | 6.95 |
| 2026-03-30 | 6.85 |
| 2026-03-27 | 6.75 |
| 2026-03-26 | 7.01 |
| 2026-03-25 | 7.05 |
| 2026-03-24 | 7.04 |
| 2026-03-23 | 7.04 |
| 2026-03-20 | 6.98 |
| 2026-03-19 | 6.99 |
| 2026-03-18 | 6.88 |
| 2026-03-17 | 6.93 |
| 2026-03-16 | 6.77 |
| 2026-03-13 | 6.69 |
| 2026-03-12 | 6.61 |
| 2026-03-11 | 6.94 |
| 2026-03-10 | 6.99 |
| 2026-03-09 | 7.13 |
| 2026-03-06 | 7.06 |
| 2026-03-05 | 7.36 |
| 2026-03-04 | 7.44 |
| 2026-03-03 | 7.28 |
| 2026-03-02 | 7.17 |
| 2026-02-27 | 7.45 |
| 2026-02-26 | 7.53 |
| 2026-02-25 | 7.45 |
| 2026-02-24 | 7.61 |
| 2026-02-23 | 7.65 |
| 2026-02-20 | 8.53 |
| 2026-02-19 | 8.41 |
| 2026-02-18 | 8.38 |
| 2026-02-17 | 8.22 |
| 2026-02-13 | 8.27 |
| 2026-02-12 | 8.18 |
| 2026-02-11 | 8.42 |
| 2026-02-10 | 8.37 |
| 2026-02-09 | 8.39 |
| 2026-02-06 | 9.75 |
| 2026-02-05 | 9.64 |
| 2026-02-04 | 9.83 |
| 2026-02-03 | 9.69 |
| 2026-02-02 | 9.70 |
| 2026-01-30 | 9.48 |
| 2026-01-29 | 9.60 |
| 2026-01-28 | 9.85 |
| 2026-01-27 | 9.98 |
| 2026-01-26 | 10.00 |
| 2026-01-23 | 10.04 |
| 2026-01-22 | 10.24 |
| 2026-01-21 | 10.15 |
| 2026-01-20 | 9.82 |
| 2026-01-16 | 9.91 |
| 2026-01-15 | 10.09 |
| 2026-01-14 | 10.06 |
| 2026-01-13 | 10.08 |
| 2026-01-12 | 10.07 |
| 2026-01-09 | 10.15 |
| 2026-01-08 | 10.15 |
| 2026-01-07 | 10.22 |
| 2026-01-06 | 10.25 |
| 2026-01-05 | 10.10 |
| 2026-01-02 | 9.77 |
| 2025-12-31 | 9.72 |
| 2025-12-30 | 9.82 |
| 2025-12-29 | 9.85 |
| 2025-12-26 | 9.88 |
| 2025-12-24 | 9.84 |
| 2025-12-23 | 9.80 |
| 2025-12-22 | 9.83 |
| 2025-12-19 | 9.67 |
| 2025-12-18 | 9.63 |
| 2025-12-17 | 9.65 |
| 2025-12-16 | 9.68 |
| 2025-12-15 | 9.86 |
| 2025-12-12 | 9.86 |
| 2025-12-11 | 10.03 |
| 2025-12-10 | 10.13 |
| 2025-12-09 | 9.88 |
| 2025-12-08 | 10.05 |
| 2025-12-05 | 10.10 |
| 2025-12-04 | 10.14 |
| 2025-12-03 | 10.17 |
| 2025-12-02 | 10.20 |
| 2025-12-01 | 10.18 |
| 2025-11-28 | 10.32 |
| 2025-11-26 | 10.42 |
| 2025-11-25 | 10.55 |
| 2025-11-24 | 10.22 |
| 2025-11-21 | 10.08 |
| 2025-11-20 | 9.69 |
| 2025-11-19 | 9.62 |
| 2025-11-18 | 9.63 |
| 2025-11-17 | 9.67 |
| 2025-11-14 | 9.71 |
| 2025-11-13 | 9.70 |
| 2025-11-12 | 9.91 |
| 2025-11-11 | 9.88 |
| 2025-11-10 | 9.63 |
| 2025-11-07 | 9.51 |
| 2025-11-06 | 9.49 |
| 2025-11-05 | 9.52 |
| 2025-11-04 | 9.40 |
| 2025-11-03 | 9.55 |
| 2025-10-31 | 9.66 |
| 2025-10-30 | 9.47 |
| 2025-10-29 | 9.49 |
| 2025-10-28 | 9.56 |
| 2025-10-27 | 9.72 |
| 2025-10-24 | 9.93 |
| 2025-10-23 | 9.82 |
| 2025-10-22 | 9.63 |
| 2025-10-21 | 9.65 |
| 2025-10-20 | 9.48 |
| 2025-10-17 | 9.24 |
| 2025-10-16 | 9.25 |
| 2025-10-15 | 9.18 |
| 2025-10-14 | 9.20 |
| 2025-10-13 | 9.29 |
| 2025-10-10 | 9.14 |
| 2025-10-09 | 9.13 |
| 2025-10-08 | 9.05 |
| 2025-10-07 | 8.79 |
| 2025-10-06 | 9.05 |
| 2025-10-03 | 9.07 |
| 2025-10-02 | 8.89 |
| 2025-10-01 | 8.83 |
| 2025-09-30 | 8.28 |
| 2025-09-29 | 7.99 |
| 2025-09-26 | 8.06 |
| 2025-09-25 | 7.95 |
| 2025-09-24 | 8.08 |
| 2025-09-23 | 8.26 |
| 2025-09-22 | 8.35 |
| 2025-09-19 | 8.31 |
| 2025-09-18 | 8.46 |
| 2025-09-17 | 8.39 |
| 2025-09-16 | 8.37 |
| 2025-09-15 | 8.26 |
| 2025-09-12 | 8.16 |
| 2025-09-11 | 8.35 |
| 2025-09-10 | 8.09 |
| 2025-09-09 | 8.30 |
| 2025-09-08 | 8.55 |
| 2025-09-05 | 8.46 |
| 2025-09-04 | 8.28 |
| 2025-09-03 | 8.01 |
| 2025-09-02 | 8.19 |
| 2025-08-29 | 8.34 |
| 2025-08-28 | 8.22 |
| 2025-08-27 | 8.14 |
| 2025-08-26 | 8.18 |
| 2025-08-25 | 8.26 |
| 2025-08-22 | 8.35 |
| 2025-08-21 | 8.02 |
| 2025-08-20 | 8.20 |
| 2025-08-19 | 8.22 |
| 2025-08-18 | 7.99 |
| 2025-08-15 | 8.05 |
| 2025-08-14 | 8.11 |
| 2025-08-13 | 8.20 |
| 2025-08-12 | 7.89 |
| 2025-08-11 | 7.71 |
| 2025-08-08 | 7.77 |
| 2025-08-07 | 7.68 |
| 2025-08-06 | 7.67 |
| 2025-08-05 | 7.77 |
| 2025-08-04 | 7.89 |
| 2025-08-01 | 8.83 |
| 2025-07-31 | 8.79 |
| 2025-07-30 | 9.10 |
| 2025-07-29 | 9.23 |
| 2025-07-28 | 9.20 |
| 2025-07-25 | 9.22 |
| 2025-07-24 | 9.08 |
| 2025-07-23 | 9.00 |
| 2025-07-22 | 8.75 |
| 2025-07-21 | 8.57 |
| 2025-07-18 | 8.75 |
| 2025-07-17 | 9.03 |
| 2025-07-16 | 8.81 |
| 2025-07-15 | 8.81 |
| 2025-07-14 | 9.26 |
| 2025-07-11 | 10.74 |
| 2025-07-10 | 10.75 |
| 2025-07-09 | 10.63 |
| 2025-07-08 | 10.58 |
| 2025-07-07 | 10.55 |
| 2025-07-03 | 10.66 |
| 2025-07-02 | 10.71 |
| 2025-07-01 | 10.86 |
| 2025-06-30 | 10.62 |
| 2025-06-27 | 10.72 |
| 2025-06-26 | 10.80 |
| 2025-06-25 | 10.65 |
| 2025-06-24 | 10.55 |
| 2025-06-23 | 10.43 |
| 2025-06-20 | 10.43 |
| 2025-06-18 | 10.33 |
| 2025-06-17 | 10.38 |
| 2025-06-16 | 10.58 |
| 2025-06-13 | 10.42 |
| 2025-06-12 | 10.64 |
| 2025-06-11 | 10.53 |
| 2025-06-10 | 10.64 |
| 2025-06-09 | 10.60 |
| 2025-06-06 | 10.69 |
| 2025-06-05 | 10.54 |
| 2025-06-04 | 10.75 |
| 2025-06-03 | 10.63 |
| 2025-06-02 | 10.46 |
| 2025-05-30 | 10.63 |
| 2025-05-29 | 10.81 |
Showing the most recent 260 of 4,779 data points. The chart above shows the full history.
Related Metrics
About Waters Corporation
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Udit Batra